Publications
Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}
Abstract
IL-15 is normally presented in vivo as a cell-associated cytokine bound to IL-15Ralpha. We show here that the biological activity of soluble IL-15 is much improved after interaction with recombinant soluble IL-15Ralpha; after injection, soluble IL-15/IL-15Ralpha complexes rapidly induce strong and selective expansion of memory-phenotype CD8(+) cells and natural killer cells. These findings imply that binding of IL-15Ralpha to IL-15 may create a conformational change that potentiates IL-15 recognition by the betagamma(c) receptor on T cells. The enhancing effect of IL-15Ralpha binding may explain why IL-15 normally functions as a cell-associated cytokine. Significantly, the results with IL-2, a soluble cytokine, are quite different; thus, IL-2 function is markedly inhibited by binding to soluble IL-2Ralpha.
Type | Journal |
---|---|
ISBN | 0027-8424 (Print) |
Authors | Rubinstein, M. P.;Kovar, M.;Purton, J. F.;Cho, J. H.;Boyman, O.;Surh, C. D.;Sprent, J. : |
Publisher Name | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
Published Date | 2006-01-01 |
Published Volume | 103 |
Published Issue | 24 |
Published Pages | 9166-71 |
Status | Published in-print |
URL link to publisher's version | http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16757567 |
OpenAccess link to author's accepted manuscript version | https://publications.gimr.garvan.org.au/open-access/2123 |